{"name":"Massachusetts Eye and Ear Infirmary","slug":"massachusetts-eye-and-ear-infirmary","ticker":"","exchange":"","domain":"masseyeandear.org","description":"","hq":"Boston","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Ophthalmology","slug":"ophthalmology","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"immunology","drugs":[{"name":"Arificial Tear","genericName":"Arificial Tear","slug":"arificial-tear","indication":"Dry eye syndrome","status":"marketed"},{"name":"Atropine 1%","genericName":"Atropine 1%","slug":"atropine-1","indication":"Mydriasis and cycloplegia for diagnostic eye examinations","status":"marketed"},{"name":"B+L Advanced Eye Relief Lubricant Drop","genericName":"B+L Advanced Eye Relief Lubricant Drop","slug":"b-l-advanced-eye-relief-lubricant-drop","indication":"Dry eye syndrome / Dry eye disease","status":"marketed"},{"name":"Visine Dry Eye Relief eye drops","genericName":"Visine Dry Eye Relief eye drops","slug":"visine-dry-eye-relief-eye-drops","indication":"Dry eye syndrome / dry eye disease","status":"marketed"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"ReNu MultiPlus® MultiPurpose Solution","genericName":"ReNu MultiPlus® MultiPurpose Solution","slug":"renu-multiplus-multipurpose-solution","indication":"Cleaning, disinfection, and storage of soft contact lenses","status":"marketed"},{"name":"Clear Care®","genericName":"Clear Care®","slug":"clear-care","indication":"Cleaning, disinfection, and storage of soft contact lenses","status":"marketed"},{"name":"Loteprednol/tobramycin","genericName":"Loteprednol/tobramycin","slug":"loteprednol-tobramycin","indication":"Steroid-responsive inflammatory ocular conditions with bacterial infection or risk thereof","status":"marketed"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"cardiovascular","drugs":[{"name":"Cultivation of Limbal epithelial cells into a graft","genericName":"Cultivation of Limbal epithelial cells into a graft","slug":"cultivation-of-limbal-epithelial-cells-into-a-graft","indication":"Other","status":"phase_1"},{"name":"Cyclosporine A 0.05%","genericName":"Cyclosporine A 0.05%","slug":"cyclosporine-a-0-05","indication":"Other","status":"marketed"},{"name":"OPTI-FREE® RepleniSH®","genericName":"OPTI-FREE® RepleniSH®","slug":"opti-free-replenish","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"ReNu MultiPlus® MultiPurpose Solution","genericName":"ReNu MultiPlus® MultiPurpose Solution","slug":"renu-multiplus-multipurpose-solution","phase":"marketed","mechanism":"ReNu MultiPlus is a multipurpose contact lens solution that cleans, disinfects, and stores soft contact lenses through chemical disinfection and surfactant-based cleaning.","indications":["Cleaning, disinfection, and storage of soft contact lenses"],"catalyst":""},{"name":"Clear Care®","genericName":"Clear Care®","slug":"clear-care","phase":"marketed","mechanism":"Clear Care® is a hydrogen peroxide-based contact lens cleaning and disinfection system that uses catalytic breakdown to remove protein and lipid deposits while disinfecting lenses.","indications":["Cleaning, disinfection, and storage of soft contact lenses"],"catalyst":""},{"name":"Arificial Tear","genericName":"Arificial Tear","slug":"arificial-tear","phase":"marketed","mechanism":"Artificial tears are lubricating eye drops that supplement or replace the eye's natural tear film to relieve dryness and irritation.","indications":["Dry eye syndrome","Ocular surface irritation and discomfort"],"catalyst":""},{"name":"Atropine 1%","genericName":"Atropine 1%","slug":"atropine-1","phase":"marketed","mechanism":"Atropine blocks muscarinic acetylcholine receptors to inhibit parasympathetic activity, causing pupil dilation and cycloplegia when applied topically to the eye.","indications":["Mydriasis and cycloplegia for diagnostic eye examinations","Accommodation disorders and strabismus management","Uveitis and anterior chamber inflammation"],"catalyst":""},{"name":"B+L Advanced Eye Relief Lubricant Drop","genericName":"B+L Advanced Eye Relief Lubricant Drop","slug":"b-l-advanced-eye-relief-lubricant-drop","phase":"marketed","mechanism":"This lubricating eye drop provides moisture and relief to dry eyes by forming a protective film on the ocular surface.","indications":["Dry eye syndrome / Dry eye disease","Eye irritation and discomfort"],"catalyst":""},{"name":"Cultivation of Limbal epithelial cells into a graft","genericName":"Cultivation of Limbal epithelial cells into a graft","slug":"cultivation-of-limbal-epithelial-cells-into-a-graft","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Cyclosporine A 0.05%","genericName":"Cyclosporine A 0.05%","slug":"cyclosporine-a-0-05","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Loteprednol/tobramycin","genericName":"Loteprednol/tobramycin","slug":"loteprednol-tobramycin","phase":"marketed","mechanism":"Loteprednol reduces ocular inflammation via glucocorticoid receptor activation, while tobramycin provides broad-spectrum bacterial coverage by inhibiting bacterial protein synthesis.","indications":["Steroid-responsive inflammatory ocular conditions with bacterial infection or risk thereof","Post-operative ocular inflammation and infection"],"catalyst":""},{"name":"OPTI-FREE® RepleniSH®","genericName":"OPTI-FREE® RepleniSH®","slug":"opti-free-replenish","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Visine Dry Eye Relief eye drops","genericName":"Visine Dry Eye Relief eye drops","slug":"visine-dry-eye-relief-eye-drops","phase":"marketed","mechanism":"Visine Dry Eye Relief lubricates and protects the ocular surface by providing artificial tears to supplement insufficient natural tear production.","indications":["Dry eye syndrome / dry eye disease"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxOVHNQaWZ2Y3ZmcTFMTWtJSzJNR1lueEdrU2Z5bFhTVEdjVkc5LWNuc0h0LThsRjVYOVJCMS0tN05VVlM4d0g2UUhCRHZud3JCb0o2dkgtS1NtaU90aUFyTDEwd19aM1JndGJTeEpTWnJfcWFBaTFub1doVzhVZUc2RFY4VjBNdTkxMjBwTEZCd2luN2dxVkJucHBiYkgtYVp6SFIwZDB1VUFLME3SAbABQVVfeXFMUDBkYlZKVXBpdVdaeXRLcUY1Y3M3V2x1aWl6OG5WX2Vjc3lCaXExOEhMR3ZmNjQ1SWhZTzVKYXNfTlpmS1BPQjdqOVp2TF9sWi1kbEVEWF9KLVFIVXJiX2FfSXh5NnZKaGZ6NGxmOTQxSklIQjZnUDZVbVNSRUtHTWhkU2FNQlIxZUpOeUxHTDh5dnRscjJLLW5tM0ZnaXVJaVR6SVlFbXBKd21xLWFzUVU?oc=5","date":"2026-02-15","type":"trial","source":"ABC News","summary":"Children with genetic deafness have hearing restored with gene therapy: Study - ABC News","headline":"Children with genetic deafness have hearing restored with gene therapy: Study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxPMm90RjRCRVZsbkF2VTFSYnAxSk8wNmxGSDBUZjFyR0g4akZfX2NyeHBJUmswZnVka0dhTS04aWJnYWZmU2N4NEF3MjdScnVsVEpMRXdZcjN3cnZnci1uY2JfUFBVWkFjNHlteGRzUnd4T2ZQWm5tbklMYW9TUlUzODBVZ2JENWJVQzhFbTVPd2hpcnBFVlNMODdNSUZMT2JUWm9NZTJaeFV6NUo0Nm9EaXNfSXhiU0ExYnNEbWp3TVdBODlRWmc?oc=5","date":"2025-08-13","type":"pipeline","source":"Healio","summary":"Rishi P. Singh, MD, FASRS, to integrate, innovate, inspire at Mass General Brigham - Healio","headline":"Rishi P. Singh, MD, FASRS, to integrate, innovate, inspire at Mass General Brigham","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxQUU01c1RUT3VINjZiVFZwQWpCYXVRb01HcDVrYTZaYm93SWFtd3dCRFBqOXAwWTFUWmRUemZhUzdUNXdwWDlPaF8xT09aQXRyU2xwbHI1c2Z0OHFWS2FTN3BibXBqTXdIRzBmd3A0c1ZiMW9nUGlsaThxTGJhcW9TOG5XMVZjXzIyZ0tLN1V0XzJrZ09rSkU5QjRkb1M2bFhWQ2d5MjNjeHE2QQ?oc=5","date":"2024-11-27","type":"pipeline","source":"Fierce Biotech","summary":"mRNA therapy reduced scar tissue in rabbits with post-surgery eye condition - Fierce Biotech","headline":"mRNA therapy reduced scar tissue in rabbits with post-surgery eye condition","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxNbVB5eHc4RUFYR2hEWU9tOVNodmlPNXQ0R3M5Q3VPbmxlSWs2QjROMUpNbUFXbGJJQ2lzUkpHYlRfdTB1Wi1ndEdaaHdPTjJuOWNyNjQ4NnY3X01FQ0gtTS1oU0dScjRJNmE4eFhpMzBkaHpISzBYOTVQTjREd0NBajlsRjY4RFdJUWV6MWZxc2dNcWs4a3Q5SEFiSlloTzIwdk1Yb1NzZi02WWVrRzlJcGFzWGZucFVaVks1bzQ5NWw?oc=5","date":"2024-07-04","type":"regulatory","source":"pharmaceutical-journal.com","summary":"Semaglutide linked to sight-threatening eye condition, study results suggest - pharmaceutical-journal.com","headline":"Semaglutide linked to sight-threatening eye condition, study results suggest - pharmaceutical","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxNZE9XbmZDUVhWekxnaEVObWlMZkl3RUN4Q01FZk5qQTRkUlRuNDNVd2w2RzlEalptbXp5aFZ5ZUF3VWJFWWdrMTNmRm1uZmZfcUttN2NYV2N6bTVEbEVXdDNmTXl3aXdMQmVIX2MwSWhtNUxlSTl6TzNjS3c0WFFQeGdGQktfR2Q3Y3dPYlh3YjgzalVCUGY0c2FBNk9fOGJrQk5adW42elF1Z1NrMGVyMw?oc=5","date":"2024-07-03","type":"trial","source":"Bloomberg.com","summary":"Ozempic Linked to Rare Cases of Vision Loss in Harvard Study - Bloomberg.com","headline":"Ozempic Linked to Rare Cases of Vision Loss in Harvard Study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxPNEFZVVRtVU93elFfUnF6emRwMHJCaVdEWWp6OTRNYzhIc3FIWHdya1BndGNURk5tTmtEdnludEp3c3hEclByMkY3VHd3MTA2WWFkRHctcDdJU0JTT0VQcEIzendjYmtKMnhuamhQaDFOdjJINkFBTTNNaGdtdzJ6aFliREhTX3o3MHg4VHBKZURNcktXRHhSelNDenpoeVlNek5Bbm5oX0M4aWFYX1E?oc=5","date":"2024-02-07","type":"pipeline","source":"SciTechDaily","summary":"Unlocking the Future of Health: Predicting Disease With Retinal Imaging and Genetics - SciTechDaily","headline":"Unlocking the Future of Health: Predicting Disease With Retinal Imaging and Genetics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxQS2tkNEhjd1N4NjNzRHROR1FJNWVkYUVoMWlmTWd6LWg3MDk0QVhDRWVzczNtc2JVSWJEMHAwTlBnallQcW1qQ25QQlJ4LS1kWFBYT3lvM0NTMFJKN3lrRmthalpPRktiUEQ5Z2hkNzBPRzE4UEhhTmFpVDlXR2YwY0g4c0RjMUN4aGVWTGE0bnc3dXYydzcxZkF3MnNCamE1OVhfLXhIWUwyS0lPSlFMS3E3YWkzaGxzYjZ1ejMxNnQxUW80d1E?oc=5","date":"2023-03-08","type":"pipeline","source":"Mass General Brigham","summary":"Mass Eye and Ear Scientist Identifies Molecule Unlocking Glaucoma - Mass General Brigham","headline":"Mass Eye and Ear Scientist Identifies Molecule Unlocking Glaucoma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxOcUxCN3FHbkMwRm9tWWRES3FTR2NybktsMzJBLXZNU0hoNjMzal84OXZGdWs1cEs4eXFRLVN1ZkxBNUZOZlhUb1RfeHRmRkZrTy1wQVpHV1RjYkpjOEF6SWRFaW9OSXlFZWtoTDktTnJHLWxUQngzb2lYc0pZdzRNUmNGLVNqRlFtVS1CU05jTTVDNEJTTV80M3RXWTkxWkxLYkd4cjNqd1hLVUlPRThQRmppNjMtRjgzS1VNRkJNOWd5QWZ3?oc=5","date":"2021-01-28","type":"pipeline","source":"Fierce Pharma","summary":"Novartis says it's ready to pitch in on manufacturing rivals' COVID-19 vaccines, diagnostics - Fierce Pharma","headline":"Novartis says it's ready to pitch in on manufacturing rivals' COVID-19 vaccines, diagnostics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxQbUh1d1hZenJ3VGFPQk0yV3o0MmRlWVRpQ3JYbmd5aWFBdUMyUklCVW9manc4T1FEZVpMRHNCeWYwVVFqdlhOR0hEU3k1SldFWm9zMTJVdkk3V0ZSS3NDWHhCWm54MHE0Rk9ObkNhbzNtQjZxZmszUkt3VUZ1ZS1VOWRqSHpURmNVRWFJejZrQ0lzS3E4cEpVUzItMzROaUt6U0NTYWZtbU51QlR5UUE?oc=5","date":"2020-05-28","type":"pipeline","source":"BioPharma Dive","summary":"Novartis teams with Mass. Eye & Ear to join coronavirus vaccine chase - BioPharma Dive","headline":"Novartis teams with Mass. Eye & Ear to join coronavirus vaccine chase","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxQbW5zYVpoTnpzSG1BU1VlZWJ5R0lOeV9maE8ydmZkU3NFRjBjaUpuZ2EybllQcU9DUDdkZXYxWXNlZDBWZEp5eXFsT3FwcF9tcFlWeW5zOXdocUdZb0VWbkVHempSNTUxVm5xYzFKZEotd1cxcHJLSS0wWHpsOGdwR3N1OFA5UQ?oc=5","date":"2019-12-04","type":"pipeline","source":"Medical Xpress","summary":"Reprogramming inner ear to regrow hair cells promising target for hearing loss treatments - Medical Xpress","headline":"Reprogramming inner ear to regrow hair cells promising target for hearing loss treatments","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPc2hvMWFYVk8yZ3RCVDRsRDhtYm5JZkVjOGVTb1ZaZW95N3NJbzR5Q3pqendqNjUyWHBhancwMUtybTktbkZ1UXJVMnBsUTJVRzBVS2locHR2c1BHZjBFOExKbC11bUdzQU5YMGd1dWpsN2ROd1d6NjVMWEw5aW5oQzJPWUVBV1p5a3dYcURpYzY3YjltUDRzTjFNdEQzUkVYYkF4SldB?oc=5","date":"2018-12-13","type":"trial","source":"The Tennessean","summary":"Meningitis outbreak: 5 convicted after two-month racketeering, mail fraud trial - The Tennessean","headline":"Meningitis outbreak: 5 convicted after two-month racketeering, mail fraud trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxNUUttN3BYMl9YcHF1azZSWmF5WXJZUlZTYzVDOUJUTmdqYnBJay1yU1BNY0VENWw5bmpyd3p0dzJHQm1ZV3QtRlRTMXp6dDdzYWtsVVdNbV9IOHhxTGFGajlQdHJPcC1fNEJxVkxCN1padmFzU1N0RXN1cDBINDZuX0lFTkg?oc=5","date":"2018-10-23","type":"pipeline","source":"Ophthalmology Times","summary":"Bascom Palmer again tops in annual survey - Ophthalmology Times","headline":"Bascom Palmer again tops in annual survey","sentiment":"neutral"}],"patents":[],"drugCount":10,"phaseCounts":{"marketed":9,"phase_1":1},"enrichmentLevel":0,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}